Christoph Meyenberg

Subcutaneous vs Intravenous Trastuzumab for Patients With ERBB2-Positive Early Breast Cancer: Final Analysis of the HannaH Phase 3 Randomized Clinical Trial

J. Ahn, B. Melichar, X. Pivot, 2019, JAMA oncology.

Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial.

D. Murphy, E. Anagnostou, J. Veenstra-VanderWeele, 2022, The lancet. Psychiatry.

Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers

L. Bubendorf, R. Stahel, S. Peters, 2018, Clinical Cancer Research.

ALINA: a phase III study of alectinib versus chemotherapy as adjuvant therapy in patients with stage IB-IIIA anaplastic lymphoma kinase-positive (ALK +) non-small cell cancer (NSCLC)

A. Shaw, J. Ahn, R. Dziadziuszko, 2019, Pneumologie.

Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials

James A. Hutchinson, A. Scheffold, J. Bluestone, 2020, The Lancet.

The ONE Study: Evaluation of Regulatory Cell Therapy in Kidney Transplantation Using a Harmonized Trial Design

A. Scheffold, J. Bluestone, R. Lechler, 2020 .